Venus Remedies trails healthcare peer margin median in Q2FY27
Operating margin was 3.98 percentage points below the 23.41% sector median, while other income made only a limited contribution to pre-tax profit.
Filed 26 Oct 2026, 18:41 IST · after market close · Venus Remedies Ltd (VENUSREM)
Key takeaways
- Consolidated operating margin was 19.43%, 3.98 percentage points below the 23.41% median for nine reported healthcare peers.
- Profit before tax of Rs 33.47 cr was primarily operational, with other income contributing Rs 0.51 cr.
- The company reported consolidated net profit of Rs 25.65 cr after a 23.36% tax rate and no interest expense.
Price around the results
Operating margin sits below the healthcare peer set
Venus Remedies reported a consolidated operating margin of 19.43% in Q2FY27. That was 3.98 percentage points below the 23.41% median among nine healthcare companies that had reported the same quarter. The company ranked third from the bottom on this measure.
Profit was driven mainly by operations
Profit before tax was Rs 33.47 cr, against operating profit of Rs 42.50 cr, with depreciation of Rs 9.54 cr accounting for the main reported reduction before tax. Other income was Rs 0.51 cr, so it was not a major contributor to pre-tax profit. There was no interest expense in the quarter.
Net profit reflects a 23.36% tax rate
Tax of Rs 7.82 cr at a 23.36% rate reduced profit before tax to consolidated net profit of Rs 25.65 cr. With no sequential or year-on-year comparison available, the quarter's key read-through is the operating margin gap versus peers rather than a direction-of-travel assessment.
Results were filed after market close
The company filed its consolidated Q2FY27 results after market close on 26 October 2026. There is no post-results market reaction to assess yet, and no historical reaction series is provided for comparison.
Q2FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 |
|---|---|
| Revenue | ₹219 cr |
| Other income | ₹1 cr |
| Expenses | ₹176 cr |
| Operating profit | ₹43 cr |
| Operating margin (%) | 19.43% |
| Interest | ₹0 cr |
| Depreciation | ₹10 cr |
| Profit before tax | ₹33 cr |
| Tax | ₹8 cr |
| Net profit | ₹26 cr |
| EPS (₹) | ₹19.19 |
Operating margin of 19.43% compares with a Healthcare sector median of 23.41% across 9 peers that have reported Q2FY27.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | -4.99% | -4.98% |
Volume on the results session was 2.55× its 20-day average.
What to watch
- Whether consolidated operating margin moves above or below 19.43%.
- Whether other income remains close to Rs 0.51 cr as a share of reported profit.
- Whether the tax rate remains close to 23.36%.